Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Autoimmunity. 2013 Jan 9;46(3):188–204. doi: 10.3109/08916934.2012.746671

Figure 3.

Figure 3

Representative surface FACS plots for lupus mice bearing the anti-laminin Ig transgene. Lymphocytes were gated based on FSC and SSC properties, with additional gating as indicated. A) Splenocytes, and B) Bone marrow for the BWF1, BXSB, and NZB backgrounds. B220 is a B cell marker. IgMa = transgenic heavy chain, IgMb = endogenous heavy chain. C) Splenocytes and bone marrow for the MRL/lpr background. CD19 is a B cell marker; the presence of abnormal B220+ T cells in MRL/lpr precludes use of B220 in this strain. Tg+ = LamH transgenic, non-Tg = nontransgenic.